Epstein Secrets

BioNTech." In a 2,700-word article, the New York Times <https://www.nytimes.com/2020/11/30/health/coronavirus- vaccines-treatments.html> (11/30, Al, McNeil, 18.61M) says that while "good news about vaccines or antibody treatments surfaces" every week, "offering hope that an end to the pandemic is at han

etinintelligence.com/d2ad675465494372ad1731e4a850eaa8? pubid=fbi> (11/30, 6:35 p.m. ET, story 2, 6.21M), Lester Holt reported that Moderna President Stephen Hoge in an interview "told me he expects approval very soon." Hoge: "We're quite optimistic actually that the vaccine is — the data speaks for itself an

hose of another candidate that is about a week ahead from Pfizer and German firm BioNTech." In a 2,700-word article, the New York Times (11/30, Al, McNeil, 18.61M) says that while "good news about vaccines or antibody treatments surfaces" every week, "offering hope that an end to the pandemic is at ha

ink it can really prevent severe disease." On NBC Nightly NewsVI (11/30, 6:35 p.m. ET, story 2, 6.21M), Lester Holt reported that Moderna President Stephen Hoge in an interview "told me he expects approval very soon." Hoge: "We're quite optimistic actually that the vaccine is - the data speaks for itself and

hose of another candidate that is about a week ahead from Pfizer and German firm BioNTech." In a 2,700-word article, the New York Times (11/30, Al, McNeil, 18.61M) says that while "good news about vaccines or antibody treatments surfaces" every week, "offering hope that an end to the pandemic is at ha

hink it can really prevent severe disease." On NBC Nightly NewsVi (11/30, 6:35 p.m. Et story 2, 6.21M), Lester Holt reported that Moderna President Stephen Hoge in an interview "told me he expects approval very soon." Hoge: "We're quite optimistic actually that the vaccine is - the data speaks for itself and